James Woodruff Lillie

Chief Scientific Officer

James Woodruff Lillie (Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in MapLight Therapeutics, Inc. (MPLT). The largest single filing was $1.4M of MPLT (49,719 sh across 5 lots, as filed), executed May 4.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.2M

shares × price, as filed

Last traded

Aug 3

Filed Aug 4

Median ADV $7.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

MPLT

MapLight Therapeutics, Inc. MPLT · 0 buys · 3 sells 3 filings

Recent filings

MPLTSALE MapLight Therapeutics, Inc. View filing → $277K
22,082 sh × $12.54
Exec Aug 3
Filed Aug 4 · 8:39 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $513K
13,928 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 9:45 PM ET MPLTSALE MapLight Therapeutics, Inc. View filing → $1.4M
49,719 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET